Net profit of Titan Biotech rose 3.90% to Rs 6.40 crore in the quarter ended June 2024 as against Rs 6.16 crore during the previous quarter ended June 2023. Sales rose 24.06% to Rs 43.11 crore in the quarter ended June 2024 as against Rs 34.75 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 43.11 | 34.75 | 24 |
| OPM % | 19.14 | 22.71 | - |
| PBDT | 8.56 | 7.88 | 9 |
| PBT | 7.52 | 7.09 | 6 |
| NP | 6.40 | 6.16 | 4 |